To temper HCQ we have the following study – https://www.nejm.org/doi/full/10.1056/NEJMoa2016638?query=featured_home

“This randomized trial did not demonstrate a significant benefit of hydroxychloroquine as postexposure prophylaxis for Covid-19. Whether preexposure prophylaxis would be effective in high-risk populations is a separate question, with trials ongoing. In order to end the pandemic, a reduction in community transmission is needed.”

“Nausea, loose stools, and abdominal discomfort were the most common side effects. There were no serious intervention-related adverse reactions or cardiac arrhythmias.”

However this is just HCQ and does not include the Zinc combination being recommended. In addition they note in their study they did not have access to testing. Another positive is the acknowledgement the side effects are minimal unlike the Lancet study.

WHO has backtracked their response to Lancet study – https://www.statnews.com/2020/06/03/who-resuming-hydroxychloroquine-study-for-covid-19/

WHO resumes hydroxychloroquine study for Covid-19, after reviewing safety concerns

Conspiracy theorist on the origin of virus going to love this – like a James Bond plot with a touch of reality as it was noted as an accidental release not a nefarious reason but why create such a virus?- https://www.walesonline.co.uk/news/world-news/coronavirus-origin-lab-mig-wuhan-18360326

Gilead details on remdesivir – https://www.axios.com/remdesivir-sales-predictions-gilead-coronavirus-adeb5473-9f7e-429b-a0a5-343903a9305a.html

“Gilead’s intravenous coronavirus drug remdesivir could fetch $6.7 billion in revenue in 2021 with a 19% profit margin, assuming the company prices each treatment at $5,000, according to new forecasts from Geoffrey Porges, a highly read pharmaceutical analyst at Wall Street firm SVB Leerink.”

“…That price would also be above what independent researchers suggest is a fair price.”

So lets compare HCQ=$19X14(days)=$266 vs. $5000 19X…which is much better than the initial cost of 10K that many noted – assuming they go with that price…not sure what that “fair” price even means. They should note how they compute a fair price – I suspect it is based on a rate of return they believe is “fair” which then would be probably an industry average return on risk adjusted basis based on investments to discover the drug and produce it.

US below 1K deaths in the middle of the week – this is a big step! Unfortunately Brazil 1349 and Mexico 1092….

Leader in the US is NJ….NY not even in top 5 in terms of daily death

Memorial day weekend impact probably coming in now given some incubation time period. There is an uptick in Tennessee and Texas in terms of confirmation. This is dropping the fatality rates in these states.

County view AZ is showing more areas on the high end

Brazil #3 in deaths

No more flattening for Brazil and Mexico. Germany has a rise.